Publication | Closed Access

Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer

Radiation TherapySingle-dose Intraperitoneal RadioimmunotherapyMedicineGynecologyCancer TreatmentImmunotherapyOncologyRadiation OncologyGynecology OncologyMinimal Residual DiseaseOvarian Cancer